REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

National Healthcare Properties, Inc. ($HLTC)

Sector: Healthcare Facilities  •  Exchange / CIK: OTC / 0001561032  •  Properties: 150 Assets
Trading at a 8.3% discount to NAV
Safety Score: 72/100 (Moderate Risk)  |  Credit: BBB

Live Share Price

$9.20
52W Range: $5.35 - $13.05

Valuation Multiples

13.9x P/AFFO
P/FFO: 13.0x  |  FFO/sh: $0.71

Net Asset Value (NAV)

$10.03
Prem/Disc: -8.3%  |  Cap: 6.54%

Dividend Cash Flow

5.54% Yield
$0.51/yr (Quarterly)  |  Payout: 77.3%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 5.6x. Portfolio leased occupancy is 90.0% with a weighted average lease term (WALT) of 6.5 years. Senior credit rating of BBB provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.1275 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
National Healthcare Properties, Inc. Flagship Commercial Portfolio United States Nationwide 18,750,000 sq ft (implied) 90.0% $1,504,500,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
1.13
Index Tracking (Market Neutral)
Annualized Alpha (α)
+107.80%
Outperforming VNQ
Sharpe Ratio (vs VNQ)
0.83 vs -0.03
+0.86 Spread
Max Drawdown (1-Yr)
-41.4% vs -11.4%
-30.0% vs VNQ
HLTC vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric HLTC VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
 1.13 1.00 +0.13 (Index Tracking (Market Neutral))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
 +107.80% 0.00% (Baseline) Outperforming VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
 0.83 -0.03 +0.86
Sortino Ratio
Downside semi-variance risk-adjusted return
 0.47 -0.03 +0.50
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
 129.3% 13.8% +115.5% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
 -41.4% -11.4% -30.0% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
 40.5% 3.1% +37.4% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
 R² 0.01 Corr: 0.12 1% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
 10.2% 51.4% -41.2% vs Benchmark
QuantStats Analytical Synthesis: HLTC displays a Beta of 1.13 relative to VNQ with 0.01 R² correlation. Annualized volatility is 129.3% (115.5% higher than VNQ at 13.8%). Trailing 12-month Alpha stands at +107.80% (Outperforming VNQ) with a Sharpe ratio of 0.83 against -0.03 for VNQ, and a maximum drawdown of -41.4%.
SEC CIK: 0001561032  |  Principal Executive Officer: Executive Leadership / National Corp  |  Total PEO Compensation: Reported in DEF 14A (N/A)
Official SEC Accession: 0001561032-26-000001
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.